[Prognostic factors related to remission duration and the effects of maintenance therapy in BHAC-DMP therapy in adult acute non-lymphocytic leukemia patients]

MeSH terms

• Acute Disease
• Adolescent
• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Cytarabine / administration & dosage
• Cytarabine / analogs & derivatives
• Deoxycytidine Monophosphate / administration & dosage
• Humans
• Leukemia / drug therapy*
• Middle Aged
• Prognosis
• Regression Analysis
• Remission Induction